Ipilimumab and Nivolumab in Leptomeningeal Metastases From Melanoma

Conditions:   Leptomeningeal Carcinomatosis;   Melanoma Interventions:   Drug: Nivolumab;   Drug: Ipilimumab Sponsors:   Massachusetts General Hospital;   Bristol-Myers Squibb Not yet recruiting - verified September 2016
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials